Enfortumab vedotin (EV) in patients (Pts) with metastatic urothelial carcinoma (mUC) with prior checkpoint inhibitor (CPI) failure: A prospective cohort of an ongoing phase 1 study Meeting Abstract
| Authors: | Petrylak, D. P.; Smith, D. C.; Flaig, T. W.; Zhang, J.; Sridhar, S. S.; Ruether, J. D.; Plimack, E. R.; Merchan, J. R.; Quinn, D. I.; Kilari, D.; Srinivas, S.; Baranda, J. C.; Lang, J. M.; Milowsky, M. I.; Galsky, M. D.; Spira, A. I.; Gartner, E. M.; Wu, C.; Melhem-Bertrandt, A.; Rosenberg, J. E. |
| Abstract Title: | Enfortumab vedotin (EV) in patients (Pts) with metastatic urothelial carcinoma (mUC) with prior checkpoint inhibitor (CPI) failure: A prospective cohort of an ongoing phase 1 study |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500425 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.431 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 431 -- Source: Wos |
